Skip to content
OpenCapital
Get started

Catalyst Pharmaceutical CPRX EBITDA

EBITDA at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$60.37M-93.8%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$53.58M-17.9%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$1.62M-107%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$124.73M-2.3%
Scholar Rock logo
Scholar RockSRRK
-$101.68M-32.6%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$43.93M-28.8%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K—
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×
P/S6.4×-0.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0×0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

$73.2Mebit+
$9.8MDepreciation Depletion & Amortization
=$83.01M

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's EBITDA?
Catalyst Pharmaceutical (CPRX) reported EBITDA of $83.01M in Q1 2026.
How has Catalyst Pharmaceutical's EBITDA changed year-over-year?
Catalyst Pharmaceutical's EBITDA increased by 14.0% year-over-year, from $72.83M to $83.01M.
What is the long-term trend for Catalyst Pharmaceutical's EBITDA?
Over 4 years (2021 to 2025), Catalyst Pharmaceutical's EBITDA has grown at a 54.0% compound annual growth rate (CAGR), from $52.58M to $295.65M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.